Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Revenue

Capricor Therapeutics had revenue of $3.97M in the quarter ending June 30, 2024, with 1.38% growth. This brings the company's revenue in the last twelve months to $27.15M, up 187.15% year-over-year. In the year 2023, Capricor Therapeutics had annual revenue of $25.18M with 886.81% growth.

• Revenue (ttm): $27.15M
• Revenue Growth: +187.15%
• P/S Ratio: 24.24
• Revenue / Employee: $266,198
• Employees: 102
• Market Cap: 999.73M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	25.18M	22.63M	886.81%
Dec 31, 2022	2.55M	2.31M	941.85%
Dec 31, 2021	244.90K	-65.35K	-21.06%
Dec 31, 2020	310.25K	-694.78K	-69.13%
Dec 31, 2019	1.01M	-666.33K	-39.87%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.